Dr. Julio Rosenstock is Director of the Dallas Diabetes and Endocrine Center at Medical City, an endocrine practice and clinical research facility, and Clinical Professor of Medicine at the University of Texas Southwestern Medical Center. He received his medical degree from the University Of Costa Rica School of Medicine. He completed fellowships in Endocrinology and Diabetes at the Royal Postgraduate Medical School, Hammersmith Hospital in London and at the University of Texas Southwestern Medical Center in Dallas. He is board certified in Internal Medicine and in Endocrinology and Metabolism. His clinical and research activities have focused on exploring novel agents and therapeutic strategies to improve glycemic control, particularly early insulin intervention with combination strategies in Type 2 Diabetes. He also has had a special interest in the development of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT2 inhibitors acting as a clinical investigator and scientific advisor. He is recognized worldwide as a key opinion leader in the field of diabetes and over the last 30 years he has participated in hundreds of clinical trials for the development of new oral agents and insulin preparations. He has authored more than 400 publications, including peer-reviewed papers and numerous abstracts, and has also contributed to several clinics and book chapters on various topics in the field of diabetes. He is currently an Associate Editor of Diabetes Care and an editorial board member of the journals Practical Diabetology, Cardiovascular Diabetology and Diabetes Management and is an active reviewer for several journals. Dr Rosenstock has chaired or been a featured speaker at multiple lectures and presentations both nationally and internationally.